Ann: Trading Halt, page-56

FWIW,

I am nervous - and trying to be realistic for Tuesday.

Some part of me tells me they knew the results would be sooner than they were telling the market to ensure that wild fluctuations didn't happen.

I think the way they have set this up is that the results will not be conclusive - there will be some efficacy from some of the end points - but the. FDA torpedoed them right at the start with the change to 10mg, from 30mg.

That's why we are running xanahes - that to me is the crucial information.

This is not dead in the water - i think there will be a next step to phase 3 at a higher dose, and the company will be keen to ensure that we investors can see that.

All conjecture and my own opinion.

GLTA, Fingers crossed.